Search
for
Sort by
Research 30 of 1000+
- New investigational drugs for androgenetic alopecia
- New drugs under investigation for the treatment of alopecias
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- Investigation of intermolecular interactions in finasteride drug crystals in view of X-ray and Hirshfeld surface analysis
- Drug discovery for alopecia: gone today, hair tomorrow
- Male pattern baldness and its management: an update.
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Role of hair as Evidence in Investigation: A Forensic Approach
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Anti-acne drugs in phase 1 and 2 clinical trials
- Prospecting for Drugs in Ancient and Medieval European Texts: A Scientific Approach (review)
- Role of Drug Repurposing in Sustainable Drug Discovery
- HAIR ANALYSIS FOR DRUGS OF ABUSE. PLAUSIBILITY OF INTERPRETATION
- Drug safety evaluation of exemestane
- Spotlight Commentary: Importance of dose redefining in the process of drug repurposing
- Lower Urinary Tract Symptoms: What’s New in Medical Treatment?
- Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia
- Hair follicles as a target structure for nanoparticles
- Primary cicatricial alopecia: diagnosis and treatment
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- HX17 The fortunate side effect: serendipity and therapeutic innovation in dermatology
- 28-Year-Old Female with Diffuse Thinning of the Scalp after Isotretinoin and Oral Contraceptives
- Solid Lipid Nanoparticles (SLN): Method, Characterization and Applications
- An Overview of the Biology of Platelet-Rich Plasma and Microneedling as Potential Treatments for Alopecia Areata
- Investigation of follicle stimulating effect of medical cosmetic remedies on the androgen alopecia model in rats
- W6: Novelties in hair analysis and interpretation issues
- New potential chemotherapy for ovarian cancer — Combined therapy with WP 631 and epothilone B
- 5 Alpha-reductase inhibitors: whatʼs new?
- An Old Problem with a New Cause-5 Alpha Reductase Inhibitors and Persistent Sexual Dysfunction
- Telogen Effluvium